US2005096283A1PendingUtilityA1

Methods of inhibiting fertility

Assignee: UNIV CALIFORNIAPriority: Dec 14, 2001Filed: Sep 26, 2003Published: May 5, 2005
Est. expiryDec 14, 2021(expired)· nominal 20-yr term from priority
C07K 14/705A61K 39/0006A61K 2039/53
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention features compositions and methods for inhibiting fertility or inducing contraception in a mammal. The compositions comprise a nucleic acid molecule, typically an immunostimulatory nucleic acid.

Claims

exact text as granted — not AI-modified
1 . A method for inhibiting fertility in a female mammal in need thereof comprising administering to the mammal a pharmaceutical composition comprising an isolated nucleic acid in an amount sufficient to inhibit fertility in the mammal.  
     
     
         2 . The method of  claim 1 , wherein the nucleic acid is an oligonucleotide.  
     
     
         3 . The method of  claim 1 , wherein the nucleic acid comprises an immunostimulatory sequence.  
     
     
         4 . The method of  claim 3 , wherein the pharmaceutical composition does not comprise an antigen against which a protective immune response is desired.  
     
     
         5 . The method of  claim 1 , wherein the mammal is a human.  
     
     
         6 . The method of  claim 1 , wherein the mammal is a dog.  
     
     
         7 . The method of  claim 1 , wherein the pharmaceutical composition is administered intradermally.  
     
     
         8 . The method of  claim 1 , wherein the pharmaceutical composition is administered orally.  
     
     
         9 . The method of  claim 1 , wherein the nucleic acid is a phosphorothioate analogue.  
     
     
         10 . The method of  claim 1 , wherein the amount sufficient to induce infertility is a dose between about 50 μg/kg and about 1 mg/kg.

Join the waitlist — get patent alerts

Track US2005096283A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.